Automotive
Find a car stock to fuel your investment strategy 🏎. This collection brings together carefully selected automotive companies, from traditional manufacturers to electric vehicle pioneers, curated by professional analysts to help you navigate this transformative industry.
Your Basket's Financial Footprint
Summary and key takeaways for the Automotive stock basket market capitalisation data provided by the user.
- Large-cap dominance generally implies lower volatility and more stable returns, tracking broad market movements rather than speculative swings.
- Best used as a core portfolio holding for diversified, long-term exposure to the automotive sector, not a speculative trade.
- Expect steady, long-term value; large-cap concentration tends to limit chances of explosive, short-term upside.
TSLA: $1.47T
GM: $62.15B
F: $49.99B
- Other
About This Group of Stocks
Our Expert Thinking
The global automotive industry is undergoing a historic transformation toward electrification and autonomous driving. With the EV market projected to reach 31 million units by 2030 and autonomous technology expected to create a $556.67 billion market by 2026, these stocks represent key players driving this revolution.
What You Need to Know
This diverse collection includes traditional manufacturers pivoting to new technologies, component suppliers enabling innovation, retail giants adapting to changing consumer habits, and pure EV players. These companies are responding to the industry's shift toward greener, smarter, and more connected mobility solutions.
Why These Stocks
Each company was selected for its strategic positioning in the evolving automotive landscape. From legacy automakers investing billions in electric futures to specialized component makers and retailers adapting to new realities, these stocks offer exposure to different aspects of the industry's transformation.
Why You'll Want to Watch These Stocks
The EV Revolution Is Just Starting
With projections showing EV sales reaching 31 million vehicles by 2030 and growing over 10% annually, these automotive stocks are positioned to benefit from a massive industry transformation.
Autonomous Tech Could Be Huge
Autonomous vehicle technology is expected to grow at 35% annually to a $2 trillion market by 2032. Companies in this collection are at the forefront of developing and implementing this game-changing technology.
You're Investing In Mobility's Future
This isn't just about cars—it's about how we'll move going forward. From electric vehicles to autonomous driving, these companies are reshaping a $3.6 trillion global industry that impacts everyone's daily life.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Global Infrastructure Partners: UAE Exposure Risks
The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.
UAE Infrastructure Global Suppliers Breakdown
As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.
Antiviral M&A Wave: Biotech Opportunities in 2025
Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.